Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours
- 20 October 2006
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 102 (1-5), 103-113
- https://doi.org/10.1016/j.jsbmb.2006.09.027
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptorCancer Gene Therapy, 2002
- Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administrationGene Therapy, 2000
- Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotidesCancer Gene Therapy, 2000
- Transfection of a reporter plasmid into cultured cells by sonoporation in vitroJapanese Journal of Clinical Oncology, 1997
- Regulation of prostatic growth and function by peptide growth factorsThe Prostate, 1996
- Androgen receptor status of lymph node metastases from prostate cancerThe Prostate, 1996
- Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesteroneMolecular Endocrinology, 1993
- Androgen receptors in endocrine‐therapy‐resistant human prostate cancerInternational Journal of Cancer, 1991
- Hormonal therapy for prostate cancerSeminars in Surgical Oncology, 1990